Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.


BACKGROUND Nausea and vomiting can occur in Parkinson's disease (PD) patients initiated on apomorphine subcutaneous injections and antiemetic prophylaxis is recommended per product labeling. Data suggest long-term antiemetic prophylaxis may not be needed, although this has not been systematically studied. METHODS We evaluated coadministered… (More)
DOI: 10.1016/j.parkreldis.2014.08.010

4 Figures and Tables


  • Presentations referencing similar topics